Protocol Ledger

NCT04055883 · Phase II · COMPLETED

Clinical Study to Evaluate Efficacy and Safety of DA-1229 in Patients With CAVD

Interventional Phase II clinical trial protocol NCT04055883 sponsored by Dong-A ST Co in Cardiovascular and Thrombosis, reconciled from NIH NLM ClinicalTrials.gov REST API v2.

Start Date: 2019-08-26 Enrollment: 228 participants (ACTUAL) Federal Source: clinicaltrials.gov/study/NCT04055883
Track in Studio / Generate Client Brief ->
Registered Enrollment vs Phase II/III Median (145 pts)228 participants (ACTUAL)
Disclosed U.S. Hospital Campuses vs Median (6 sites)4 sites

Reconciled ClinicalTrials.gov v2 Protocol Specification

Structured Registry Fields for NCT04055883
Protocol FieldVerified Registry Value
NCT IdentifierNCT04055883
Consolidated Lead SponsorDong-A ST Co
Therapeutic Condition CohortCardiovascular and Thrombosis
Clinical Trial PhasePhase II
Overall Recruitment StatusCOMPLETED
Registered Enrollment228 participants (ACTUAL)
Registered Start Date2019-08-26
WhyStopped ClassificationNot Stopped

Named U.S. Hospital Clinical Research Sites

Canonical Hospital Campuses Listed on NCT04055883
Hospital Research SiteLocationSite Profile
Seoul National University Bundang HospitalSeongnam-si, South KoreaOpen Hospital Dossier ->
Chonnam National University HospitalGwangju, South KoreaOpen Hospital Dossier ->
Gangnam Severance HospitalSeoul, South KoreaOpen Hospital Dossier ->
Samsung Medical CenterSeoul, South KoreaOpen Hospital Dossier ->

Search related sites and sponsors in the Interactive Directory, explore Cardiovascular and Thrombosis Benchmarks, or read the Healthcare Price & Patent Cliff Crosswalk.

Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI